Gary Schwartz, chief of the Hematology & Oncology Division at Columbia University Irving Medical Center and deputy director of its Herbert Irving Comprehensive Cancer Center, was named director of Case Comprehensive Cancer Center.
Kevin J. Cullen, the longtime director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center and the Program in Oncology at the University of Maryland School of Medicine, will transition from these leadership positions in 2023.
David F. Jarrard was named deputy director of UW Carbone Cancer Center.
Wm. Kevin Kelly was appointed chair of the Department of Medical Oncology for the Sidney Kimmel Medical College at Thomas Jefferson University, effective Jan. 1.
Faye Rogers, associate professor of therapeutic radiology, was appointed associate cancer center director for DEI at Yale Cancer Center.
Douglas Gladstone was named chief of hematologic malignancies at the Northwell Health Cancer Institute.
Rhonda Curry was named chief marketing and communications officer at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
A Cure in Sight Ocular Melanoma and the HonorHealth Research Institute Melanoma Clinic formed a collaboration to establish a Biorepository of Metastatic Uveal Melanoma, a multisite biobank of metastatic uveal samples to be used in studies that will lead to a better understanding of the disease.
The American Association for Cancer Research and the African Organisation for Research and Training in Cancer announced four grants to promote and support early-career investigators in Africa as they begin to establish careers in cancer research.
Recent policy changes help increase access to recommended non-invasive colorectal cancer screening tests. These policy changes require Medicare and most commercial insurers to pay for colonoscopy after a positive Cologuard test without cost to the patient. For most patients, these financial protections take effect starting Jan. 1.
